Oral pharmacotherapy of childhood movement disorders

Area of Science:

• Pediatric Neurology
• Movement Disorders
• Neuromuscular Diseases

Background:

• Movement disorders are a significant challenge in pediatric neurology, impacting children with neurological impairments.
• Distinct differences exist between adult and childhood movement disorders, often presenting insidiously with mild hypotonia.

Purpose of the Study:

• To review current empiric drug use for childhood movement disorders.
• To provide evidence-based recommendations for managing pediatric movement disorders.

Main Methods:

• Literature review of empiric drug use in pediatric movement disorders.
• Analysis of clinical manifestations and age-of-onset influences on extrapyramidal disorders.
• Synthesis of current treatment recommendations.

Main Results:

• Childhood movement disorders manifest as abnormalities in movement and posture, frequently with muscle tone disturbances.
• Age at onset profoundly influences the clinical expression of extrapyramidal disorders.
• Empiric drug use is common, necessitating careful consideration of efficacy and safety.

Conclusions:

• Effective management of childhood movement disorders requires understanding age-specific presentations and treatment nuances.
• Further research is needed to establish definitive pharmacologic guidelines for pediatric movement disorders.
• This review offers a framework for clinicians managing these complex conditions.